粒细胞集落刺激因子对靶细胞的作用机制及其常用制剂的临床药理研究和应用进展(7)
[38] LEE KH，KIM JY，LEE MH，et al. A randomized，multicenter，phase Ⅱ/Ⅲ study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients：KCSG PC10-09[J]. Support Care Cancer，2016，24(4)：1709- 1717.[39] MISRA H，BERRYMAN J，JUBIN R，et al. A phase Ⅰ study to determine safety，pharmacokinetics ......
您现在查看是摘要页，全文长 3662 字符。